drugset / Trial / NCT04439396
Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.
Timeline
- Start
- 2020-06-22
- Primary completion
- 2023-01-30
- Completion
- 2023-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac Tromethamine | Small molecule | 15 mg | — |
| Subject | Ketorolac Tromethamine | Small molecule | 30 mg | — |
Indications
No indication recorded.